Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/2003
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2450726A1 Cream for treating photoinduced skin damage comprising lipoic acid, coenzyme q-10 and acetyl-l-carnitine
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308447A1 Purine derivatives having antiproliferative properties and biological uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308444A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha Levels
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308165A1 Skin wound healing promoters
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307245A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
05/07/2003EP1307225A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307217A2 Vip-related peptides for the treatment of skin disorders
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307181A1 Novel compositions of minoxidil
05/07/2003EP1307180A1 A method of preparing a pharmaceutical composition
05/07/2003EP1200106B1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
05/07/2003EP1131326B1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules
05/07/2003EP1061963B1 Protease inhibitors in absorbent articles
05/07/2003EP1045822B1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0812184B1 Nitric oxide synthase inhibitors
05/07/2003CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416343A Skin whiteners contg. hydroxytetronic acid
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1415356A Medicament containing snail powder
05/07/2003CN1415349A Scorpion medicament for curing psoriasis and its producing method
05/07/2003CN1415347A Formula for curing anaphylactoid purpura
05/07/2003CN1415345A Drug for curing scald, hrut and inflammations as well as hemorrhoids
05/07/2003CN1415337A Spraying preparation for curing skin disease
05/07/2003CN1415322A Externally-used paste for curing dermatitis
05/07/2003CN1415315A Chinese traditional medicine for treating psoriasis
05/07/2003CN1415310A Nano selenium of chitin and its preparation method
05/07/2003CN1415306A Health-care mud of alga
05/07/2003CN1415300A Chilblain ointment of chloramphenicol
05/07/2003CN1107669C 维生素d类似物 Vitamin d analogues
05/07/2003CN1107519C Medicinal compsn. for treating alopesia
05/07/2003CN1107512C External-applied Chinese-medicinal liniment for treating alopecia areata, seborrheic alopecia and bald
05/07/2003CN1107510C Burn and scald treating medicine and its prepn.
05/07/2003CN1107506C Medicine for treating tinea and its prepn. method
05/07/2003CN1107503C Optically pure compoun as medicinal use
05/07/2003CN1107499C Nitric oxide donor compsns. and method for treating anal disorders
05/07/2003CN1107495C Desquamation compsns.
05/06/2003USRE38115 Treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction
05/06/2003US6559183 Nano-emulsion of 5-aminolevulinic acid
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559160 These compounds and compositions bind to the CXCR3 chemokine receptor and are useful for treating diseases and conditions responsive to the modulation of CXCR3 activity, such as multiple sclerosis, rheumatoid arthritis, psoriasis, cancer,
05/06/2003US6559131 Fucan increases the expression and/or the activity of a fibroblastic metalloproteinase or that inhibits leukocyte elastase, or both for treating a periodontal pathology or a dermal pathology
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6558925 Stem cell inhibitor
05/06/2003US6558710 Zinc oxide, its hydrated complex with glycine or lycine and free anhydrous glycine; healing skin; minimizing irritation without loss of efficacy
05/06/2003US6558658 Delivery of poly (ethylene glycol)-modified molecules from degradable hydrogels
05/06/2003US6558655 Substituted with at least one hydroxyl group or alkoxy radical.
05/06/2003CA2186017C Soap composition
05/06/2003CA2106955C Product and method for improving keratinocyte adhesion to the dermis
05/06/2003CA2032864C Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
05/02/2003EP1306387A1 Drugs or cosmetics
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1306090A1 Cosmetics or dermatological preparations containing polymers having phosphorylcholine side chain
05/02/2003EP1306089A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics or calcium antagonists
05/02/2003EP1306088A1 Combination of a benzimidazole having angiotensin-II antagonistic activity with a diuretic
05/02/2003EP1306081A1 Cosmetic use of DHEA-derivatives
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/02/2003EP1305300A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
1 ... 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 ... 1065